UK - Midven backs Alzheimer's disease testing company with £1.25m
Midven has lead a £1.25m funding round into Cytox, a Birmingham medical sciences company which is developing a diagnostic test to facilitate the early identification of Alzheimer’s disease. NESTA and a group of serial angel investors were the other investors in the round.
More on Early-stage
Sidekick spinoffs: Insurtech scale-ups attract PE interest
Investment set to break EUR 1.1bn mark this year as sponsors seek for rising stars
World Fund leads EUR 128m raise for quantum computing group IQM
Series-A2 for Finnish startup focused on combating the climate crisis also backed by the EIB
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
Latest News
Mobilab signs deal with Armira in crowded small-cap auction
Founder-owned data applications and infrastructure provider drew sponsor and strategic interest
AnaCap spin-out Veld makes team changes as it looks to raise its next fund
Hiring of Richard Kirkby and promotion of Konstantin Karchinov and Sebastien Wigdo comes eight months into the firm’s existence as an independent entity
Golding opens office in Milan and appoints new head of Italy
Former managing director Laura Tardino will lead asset manager’s expansion in Southern Europe
Archimed closes MED II on EUR 3.5bn
Healthcare-focused GP took 17 months to raise its second mid-cap fund, which has already deployed almost EUR 1bn